Blister pack with dollars instead of pills Johnson & Johnson will voluntarily disclose this price in its direct-to-consumer commercials, starting with ads for blood thinner Xarelto by late March. (Photo: Shutterstock)

Johnson & Johnson appears to have listened to President Donald Trump’s State of the Union Address.

Trump, in a portion of his speech devoted to health care, called on pharmaceutical companies to reveal “real prices” – presumably a reference to an administration proposal that would require drugmakers to show the full sticker price, or list price, of medicines in TV ads. J&J is jumping the gun, with plans to voluntarily disclose this price in its direct-to-consumer commercials, according to a blog post released Thursday. The company will start with ads for blood thinner Xarelto by late March, and then move on to other medicines. It’s the first drugmaker to announce such a step.

Complete your profile to continue reading and get FREE access to BenefitsPRO.com, part of your ALM digital membership.

Your access to unlimited BenefitsPRO.com content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical BenefitsPRO.com information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com

Already have an account?

 

BenefitsPRO

Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.